Medtide Inc.

HK$19.82As of Sun 8 Nov 2026, 12:00 UTC
HKEX:3880Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 10.89%
Biotechnology
Beta (5Y) —
PE TTM 14.41
TSR TTM (35.23%)
Mkt cap HK$2.810B
ROIC 25.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$20
(0.72%)
(25.44%)
Hold 1|9|6|9|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.26
0.29
0.30
0.30
21.38%
26.79%
22.40%
27.27%
Revenue¥M
174.1
184.0
192.6
188.7
8.66%
15.45%
20.66%
13.74%
Peers (US$356.5M)
Cap (US$)
PE
357.0M
—
Capital
TTM
5Y
10Y
Leveragex
1.234
0.154
0.143
EBIT/Intx
0.754
0.344
0.304
Own earn%
(55.52)
(2.86)
(9.19)
Sh yield%
41.17
15.98
13.87
Owners
Insiders/Inst%
3.52
57.54
Short interest%
3.92
SBC / revenue%
3.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
13–18
$1 testx
—
Incr. ROIC%
3